1. Introduction

Biometric Fertility Governance Accountability is an emerging interdisciplinary legal concept concerning the lawful, ethical, transparent, and accountable use of biometric data and automated technologies in fertility-related decisions.

It examines how governments, hospitals, fertility clinics, employers, insurers, research institutions, and technology companies collect and use sensitive biological or biometric information to make decisions concerning:

Fertility assessment and reproductive health.

In-vitro fertilisation (IVF) and assisted reproductive technologies.

Access to reproductive healthcare and fertility treatment.

Pregnancy detection and reproductive health monitoring.

Genetic testing, embryo selection, and reproductive research.

Fertility-related insurance, employment, and public-benefit decisions.

Automated reproductive-risk classification and algorithmic prioritisation.

The concept is not, by itself, a universally recognised legal doctrine or a single statutory cause of action. Rather, it brings together established legal principles involving privacy, bodily autonomy, informed consent, equality, data protection, medical negligence, administrative accountability, and reproductive rights.

The central legal question is:

Who is legally responsible when biometric information or an automated decision-making system influences a person's reproductive choices, access to fertility treatment, or reproductive privacy?

In India, this question is particularly relevant to constitutional privacy, the Digital Personal Data Protection Act, 2023, the Assisted Reproductive Technology (Regulation) Act, 2021, and the Surrogacy (Regulation) Act, 2021, alongside applicable medical and professional standards.

2. Meaning and scope of the concept

A. Biometric data

Biometric data is information derived from a person's physical, physiological, or behavioural characteristics that can identify or authenticate that person. Examples include fingerprints, facial geometry, iris patterns, and voice characteristics.

Fertility systems may also process sensitive reproductive and physiological information, including menstrual-cycle patterns, hormone measurements, ovulation indicators, pregnancy-test results, genetic information, and reproductive-health records.

An important distinction is necessary: not every fertility or health measurement is legally a biometric identifier. Hormone levels and menstrual-cycle records are reproductive-health data, while fingerprints and facial templates are conventional biometric identifiers. Both categories can raise significant privacy concerns, but the applicable legal classification may differ.

B. Fertility governance

Fertility governance refers to the rules, institutions, clinical practices, and technical systems that influence decisions about reproduction. It encompasses the licensing of fertility clinics, the regulation of assisted reproductive technology, the management of reproductive records, the protection of patients, and the oversight of automated systems.

C. Accountability

Accountability means that organisations using these technologies must be able to explain and justify their decisions, demonstrate compliance with applicable law, prevent foreseeable harm, and provide remedies when rights are violated.

For example, if a fertility clinic uses an algorithm to rank patients for treatment, accountability requires examining the quality of the data, the criteria used, the possibility of discriminatory outcomes, the involvement of qualified medical professionals, and the availability of an effective complaint or review process.

3. Legal framework in India

A. Constitutional protection

The Indian Constitution provides the foundation for accountability in fertility-related biometric systems.

Article 14 — Equality before the law: Protects against arbitrary state action and supports challenges to discriminatory fertility policies or unjustified automated classifications.

Article 21 — Life and personal liberty: Protects privacy, dignity, bodily integrity, and reproductive autonomy.

Article 19 — Relevant freedoms: May apply where a biometric surveillance practice also interferes with a protected freedom.

Article 32 and Article 226: Provide constitutional remedies before the Supreme Court and High Courts, respectively, where their requirements are satisfied.

These provisions are especially important when a public hospital, government authority, or state-supported reproductive programme uses biometric information to determine eligibility, monitor patients, or restrict access to services.

B. Assisted Reproductive Technology (Regulation) Act, 2021

The Assisted Reproductive Technology (Regulation) Act, 2021 is a principal statute governing fertility clinics and ART banks.

India Code+1

Important provisions include:

IndiaCode+3

Legal significance: A clinic cannot treat a patient's biometric authentication as a substitute for the consent required for fertility treatment. Nor does consent to treatment automatically authorise every additional use of reproductive data, such as commercial profiling, unrelated research, or disclosure to third parties.

C. Surrogacy (Regulation) Act, 2021

The Surrogacy (Regulation) Act, 2021 provides a further regulatory framework for surrogacy arrangements and oversight institutions. Its provisions must be read alongside the ART Act and applicable rules.

legislations.in+1

Accountability questions arise where medical records, identity verification, eligibility assessments, or reproductive information are used in surrogacy-related decisions. Such uses must comply with the applicable statutory requirements and constitutional safeguards; biometric technology does not independently create a legal power to impose eligibility restrictions.

D. Digital Personal Data Protection Act, 2023

The Digital Personal Data Protection Act, 2023 is relevant to digital fertility records and identifiable reproductive-health information. The Act's implementation is phased: the November 2025 commencement notification schedules different provisions for different dates. Therefore, as of 28 October 2026, it is important to distinguish provisions already in force from provisions scheduled to commence later.

E-Gazette+1

The practical legal analysis should consider:

Whether identifiable fertility data is being processed under an applicable legal basis.

Whether the required notices, consent or other statutory conditions have been satisfied.

Whether data security and lawful disclosure requirements are being observed.

Whether the relevant data-subject rights and remedies are in force at the time of the conduct.

Whether the ART Act imposes additional confidentiality or record-management obligations.

The DPDP Act does not automatically classify all reproductive-health data as a special category of biometric data. Classification and applicable duties depend on the information, processing activity, and relevant provisions.

4. Leading case laws

There is no single reported Indian Supreme Court judgment establishing a freestanding doctrine called “Biometric Fertility Governance Accountability.” The following decisions nevertheless provide important legal foundations for analysing it.

Case 1: Suchita Srivastava v. Chandigarh Administration (2009)

Citation: (2009) 9 SCC 1; AIR 2010 SC 235

Facts: The case concerned a woman with an intellectual disability who became pregnant while residing in a government institution. The dispute involved whether the pregnancy could be terminated without her consent.

Decision and principle: The Supreme Court recognised that reproductive choice is an aspect of personal liberty under Article 21. Reproductive autonomy includes choices to procreate and not to procreate, subject to the applicable legal framework. The Court emphasised bodily integrity, dignity, and privacy.

Indian Kanoon+1

Application to biometric fertility governance:

A fertility algorithm cannot replace the patient's legally required consent.

Reproductive decisions should not be dictated solely by automated risk scores.

Sensitive reproductive information must be handled in a manner consistent with dignity and autonomy.

Decisions affecting reproductive liberty require appropriate legal and clinical justification.

Legal lesson: Technological convenience cannot override reproductive autonomy.

Case 2: Justice K.S. Puttaswamy (Retd.) v. Union of India (2017)

Citation: (2017) 10 SCC 1

Facts: A nine-judge Constitution Bench considered whether privacy is a fundamental right under the Indian Constitution in proceedings arising from challenges concerning Aadhaar.

Decision and principle: The Court unanimously recognised privacy as a constitutionally protected right under Article 21 and the freedoms in Part III. The judgment linked privacy with dignity, autonomy, bodily integrity, and intimate personal choices.

Indian Kanoon+1

The judgment also established a framework for assessing state intrusions on privacy, including legality, a legitimate state purpose, and proportionality.

Application:

Suppose a public fertility hospital collects facial scans, fingerprints, menstrual-cycle data, and genetic information. If it uses those records for purposes beyond the lawful clinical or administrative objective, the following questions arise:

Is there a valid legal basis for the processing?

Is the purpose legitimate?

Is the collection necessary and proportionate?

Are adequate safeguards in place against unauthorised access or disclosure?

Is the data being used to make decisions unrelated to the purpose for which it was collected?

Legal lesson: Reproductive information can engage the constitutional protection of intimate personal life. A biometric system is not constitutionally valid merely because it is technically efficient.

Case 3: Devika Biswas v. Union of India (2016)

Citation: (2016) 10 SCC 726

Facts: The petitioner challenged the conduct of sterilisation procedures, including procedures performed in unsafe and unhygienic conditions without adequate counselling or safeguards.

Decision and principle: The Supreme Court addressed deficiencies in sterilisation programmes, patient safety, informed decision-making, and governmental responsibility. It emphasised the need for corrective action and accountability for negligent conduct.

Indian Kanoon+1

Application:

The case is relevant when biometric systems are introduced into public reproductive-health programmes. For example, a government programme might use biometric attendance and automated targets to measure the performance of family-planning workers. If those targets encourage coercive procedures or undermine genuine consent, the problem is not solved by showing that the patient was successfully authenticated.

Accountability requires attention to actual clinical practice, informed consent, safety, supervision, and remedies.

Legal lesson: Administrative efficiency and numerical targets cannot displace reproductive rights or patient safety.

Case 4: X v. Principal Secretary, Health and Family Welfare Department (2022)

Citation: (2023) 9 SCC 433; 2022 INSC 740 (interim order), followed by final judgment of 29 September 2022

Facts: An unmarried woman sought termination of a pregnancy arising from a consensual relationship. The dispute concerned the application of the Medical Termination of Pregnancy Act, 1971, and its rules to unmarried women.

Decision and principle: The Supreme Court interpreted reproductive-health legislation in light of bodily autonomy, personal liberty, and the objective of ensuring access to lawful abortion. Its September 2022 judgment rejected an interpretation that would exclude unmarried women from relevant protections merely because they were unmarried.

Indian Kanoon+2

Application to biometric fertility governance:

Automated systems should not use marital status as an unjustified proxy for reproductive eligibility.

A person's reproductive history should not be used to impose moral judgments or arbitrary restrictions.

Eligibility decisions must follow applicable legislation rather than hidden algorithmic assumptions.

Patients should have meaningful opportunities to challenge inaccurate or discriminatory classifications.

Legal lesson: Reproductive-health decisions must respect personal autonomy and equality within the governing statutory framework.

Case 5: Justice K.S. Puttaswamy (Retd.) v. Union of India — Aadhaar judgment (2018)

Citation: (2019) 1 SCC 1

Facts: The Supreme Court examined constitutional challenges to the Aadhaar identification system, including biometric collection, authentication, data retention, and mandatory use in specified contexts.

Decision and principle: The Court upheld parts of the Aadhaar framework while invalidating or restricting other aspects. The majority examined privacy, statutory authority, proportionality, and safeguards against misuse.

National Digital Library of India+1

Application: If a fertility programme requires Aadhaar authentication, the legality of that requirement must be assessed under the Aadhaar Act and applicable judgments, not assumed from the mere fact that the programme is government-operated.

For example, a clinic should distinguish between:

Verifying identity for a legally authorised purpose.

Collecting additional biometric information for its own convenience.

Linking identity records to reproductive histories.

Sharing identifiable records with employers, insurers, or unrelated commercial entities.

These activities are legally distinct. Authority to verify identity does not automatically establish authority for all subsequent processing.

Legal lesson: Biometric collection and reuse must remain within the boundaries of the applicable law and its safeguards.

5. Core accountability principles

The cases above support a practical framework for evaluating fertility-related biometric systems.

1. Lawful purpose and proportionality

An organisation should identify the legal basis for collecting information, establish a legitimate purpose, and avoid collecting more data than is reasonably necessary. Public authorities must additionally satisfy applicable constitutional requirements.

2. Informed consent

Patients must receive appropriate information about treatment, risks, and relevant uses of reproductive material. Consent to medical treatment should not be treated as blanket consent to unrelated biometric profiling or commercial data sharing.

3. Equality and non-discrimination

Systems should be tested for unjustified exclusion based on sex, disability, socioeconomic circumstances, or other protected or legally relevant characteristics. An adverse statistical outcome alone does not establish unlawful discrimination, but it may warrant investigation.

4. Explainability and human review

A patient should be able to obtain a meaningful explanation of a consequential fertility decision and seek review by an appropriately qualified clinician or competent authority. The precise legal entitlement depends on the applicable law and circumstances.

5. Confidentiality and security

Clinics and banks must protect reproductive records, maintain appropriate access controls, and comply with statutory confidentiality and retention duties. A data breach may trigger separate legal obligations and potential liability.

6. Remedies and institutional responsibility

Organisations should maintain complaint procedures, preserve relevant evidence, investigate failures, correct harmful decisions, and provide remedies where legally required.

6. Who is accountable when a fertility system causes harm?

Responsibility depends on the conduct, the applicable statute, the contractual arrangements, and the evidence. Multiple parties may have overlapping responsibilities.

These are potential forms of responsibility, not automatic findings of liability. For instance, a software developer is not necessarily legally responsible for every decision made by a clinic using its product. Liability requires analysis of the relevant duty, breach, causation, applicable defences, and available remedy.

7. Illustrative legal scenarios

The following hypothetical examples demonstrate how the accountability framework might operate.

Scenario A: Fertility treatment denied by an algorithm

A fertility clinic uses an automated scoring system to rank patients. The system repeatedly assigns lower scores to patients with disabilities or to those from particular socioeconomic backgrounds.

Legal analysis: The clinic should investigate the model's criteria, data quality, clinical validity, and discriminatory effects. If the system produces arbitrary or unlawful decisions, constitutional equality principles may apply to a public authority, while statutory, contractual, or other applicable legal protections may govern a private clinic.

Potential remedies: Internal review, regulatory complaint, correction of inaccurate data, reassessment by a clinician, or litigation where a valid cause of action exists.

Scenario B: Reproductive data disclosed to an employer

A fertility application collects menstrual-cycle and ovulation data. The application provider subsequently shares identifiable records with an employer without an adequate legal basis.

Legal analysis: The relevant questions include whether the information was identifiable personal data, what notice or consent was given, whether disclosure was legally authorised, and which data-protection provisions were in force when the disclosure occurred. The confidentiality requirements of applicable medical and ART laws may also be relevant.

Potential remedies: A complaint to the appropriate authority, a demand to stop unlawful processing, and any statutory or judicial remedy available under the applicable framework.

Scenario C: Wrong embryo or gamete identification

An ART facility relies on a faulty identification system and associates a reproductive sample with the wrong patient.

Legal analysis: This may raise issues of clinical negligence, breach of statutory duties, defective recordkeeping, consent, causation, and serious interference with reproductive autonomy. Sections 22, 23, and 28 of the ART Act are particularly relevant to consent, records, and the security and identification of reproductive material.

India Code+1

Potential remedies: Investigation, preservation of records, appropriate clinical intervention, compensation where legally established, and regulatory action.

8. Regulatory gaps and future legal development

Biometric Fertility Governance Accountability is also useful as a framework for identifying unresolved regulatory questions.

A. No unified biometric fertility code

India's ART legislation, constitutional jurisprudence, identity-verification rules, and data-protection framework address different parts of the problem. They do not necessarily provide a single, comprehensive set of rules specifically for AI-based fertility scoring or reproductive biometric surveillance.

B. Uncertain allocation of responsibility

Where a clinic purchases an external algorithm, responsibility may be distributed among the clinic, software provider, data supplier, and institution overseeing the programme. Contracts can allocate some responsibilities between parties, but they cannot necessarily eliminate statutory or constitutional obligations.

C. Limited transparency

A fertility decision may depend on a model that is difficult for patients or clinicians to understand. Good governance requires adequate documentation, validation, independent auditing where appropriate, and meaningful review of consequential decisions.

D. Secondary use of sensitive information

Information initially collected for treatment may later be used for research, product development, prediction, or commercial analytics. Each additional use must be assessed against applicable consent, confidentiality, research, and data-protection requirements.

E. Unequal access to redress

Patients may not know how to challenge an automated decision or obtain their clinical records. Accessible complaint procedures and effective regulatory supervision are therefore important elements of accountability.

9. Recommended accountability model

A responsible fertility institution should adopt a documented governance process covering the entire data lifecycle.

Stage 1 — Collection

Identify the purpose, legal basis, necessary data, and consent requirements.

Stage 2 — Processing

Validate data quality, access permissions, security, and algorithmic performance.

Stage 3 — Decision

Use qualified clinical judgment, explain consequential outcomes, and allow appropriate review.

Stage 4 — Oversight

Maintain records, conduct audits, investigate complaints, and report incidents when required.

Stage 5 — Remedy

Correct errors, protect affected patients, and provide available legal or clinical remedies.

This model is a proposed governance framework, not a statutory sequence that every Indian fertility institution is expressly required to follow in precisely this form.

10. Conclusion

Biometric Fertility Governance Accountability connects reproductive autonomy with the responsible management of biometric identifiers, reproductive-health records, and automated fertility decisions.

The most important Indian judicial authorities are:

Suchita Srivastava v. Chandigarh Administration (2009) — reproductive choice and bodily autonomy.

Justice K.S. Puttaswamy v. Union of India (2017) — constitutional privacy, dignity, and proportionality.

Devika Biswas v. Union of India (2016) — reproductive healthcare, patient safety, and governmental accountability.

X v. Principal Secretary, Health and Family Welfare Department (2022) — reproductive autonomy and equality in access to lawful abortion.

Justice K.S. Puttaswamy v. Union of India (Aadhaar judgment, 2018) — biometric identification, privacy safeguards, and proportionality.

Together, these cases support the proposition that reproductive technology must operate within a framework of lawful authority, meaningful consent, confidentiality, equality, and effective oversight. They do not, however, establish an independent cause of action under the specific label “Biometric Fertility Governance Accountability.”

The central legal principle is that technological systems may assist reproductive healthcare, but they cannot displace applicable law, informed consent, clinical responsibility, or constitutionally protected reproductive autonomy.

Research note: This is a general legal explanation focused on India. For a case-specific opinion, the exact technology, organisation involved, date of the conduct, and applicable statutory provisions would need to be examined.